Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP473847.RAzxw37_daGOrQbK3hcyPdAp6XqUUAz1iszJRef5vSwUg130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473847.RAzxw37_daGOrQbK3hcyPdAp6XqUUAz1iszJRef5vSwUg130_provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP111764.RARk2gAyMbELmye3XYZQdvugbjNrmuHHnLHRUwKpPkrao130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111764.RARk2gAyMbELmye3XYZQdvugbjNrmuHHnLHRUwKpPkrao130_provenance.
• NP111905.RAZsAhJbCbUv-TCmqJtEEC3GcUOmbz5YI1UXTIYEQQn8c130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111905.RAZsAhJbCbUv-TCmqJtEEC3GcUOmbz5YI1UXTIYEQQn8c130_provenance.
• NP112198.RAeKuDMfJ4Fo-DWVIbFvG9StTfZ51EO3QJN2U3gbXJt_8130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112198.RAeKuDMfJ4Fo-DWVIbFvG9StTfZ51EO3QJN2U3gbXJt_8130_provenance.
• NP111763.RAgClrTPRgO3-qtbW2unNNYhD_gDZj0Ee_Uut9Ro9SJLg130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111763.RAgClrTPRgO3-qtbW2unNNYhD_gDZj0Ee_Uut9Ro9SJLg130_provenance.
• NP111904.RAuX-Z5IZcX3YyJTGYlgO7NDwzN1vmggjOB5Akc5x1jfk130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111904.RAuX-Z5IZcX3YyJTGYlgO7NDwzN1vmggjOB5Akc5x1jfk130_provenance.
• NP111907.RAqVEsNZyNTH-0q8l1oanD5ERHjGhJlCc188FW5_uj1P4130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111907.RAqVEsNZyNTH-0q8l1oanD5ERHjGhJlCc188FW5_uj1P4130_provenance.
• NP112199.RAo617Lqgk5u5Q8h-vwPiSHS-X4-VSk6Nu7XCjU2KsXFg130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112199.RAo617Lqgk5u5Q8h-vwPiSHS-X4-VSk6Nu7XCjU2KsXFg130_provenance.
• NP123445.RAXQTXHQgTYyKeWnUceaGBTzjW_9stcpcaH29spGb6s_g130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123445.RAXQTXHQgTYyKeWnUceaGBTzjW_9stcpcaH29spGb6s_g130_provenance.
• NP123439.RADEQl8HainS8PSp9cWpvxar0Ow5M_525b3OMe8L6rhaU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123439.RADEQl8HainS8PSp9cWpvxar0Ow5M_525b3OMe8L6rhaU130_provenance.
• NP339900.RAmGoOfke0uDX9b2OXmn35bo4cjefTiRJfaEJcrp-ctIU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339900.RAmGoOfke0uDX9b2OXmn35bo4cjefTiRJfaEJcrp-ctIU130_provenance.
• NP123441.RAh1MGVM2aNh3LQhB36ibaJYOnU3V2bYCKXD32Z3NeqIs130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123441.RAh1MGVM2aNh3LQhB36ibaJYOnU3V2bYCKXD32Z3NeqIs130_provenance.
• NP123443.RAqQduh_vobjKGEbOb_Mrjbz7buuG4oDvNSBXfnAnxLSM130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123443.RAqQduh_vobjKGEbOb_Mrjbz7buuG4oDvNSBXfnAnxLSM130_provenance.
• NP123447.RAjJ5UMvi88XLRq8xSXCeOM7GD7QBupOlZBDXOHz7n3MM130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123447.RAjJ5UMvi88XLRq8xSXCeOM7GD7QBupOlZBDXOHz7n3MM130_provenance.
• NP112193.RA91yDiVmR7gI7US3-Fy8vo37fBgr02MBhJ2emV0OQvNQ130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112193.RA91yDiVmR7gI7US3-Fy8vo37fBgr02MBhJ2emV0OQvNQ130_provenance.
• NP672362.RAo9dhObikU-KWEt7VfoLPYs7tygmUa8CaKqIY7l1RJks130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP672362.RAo9dhObikU-KWEt7VfoLPYs7tygmUa8CaKqIY7l1RJks130_provenance.
• NP111765.RA4QOpk2aIGl0wE4Bvguc3VOp1adMT23KXCd0AplLrCYs130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111765.RA4QOpk2aIGl0wE4Bvguc3VOp1adMT23KXCd0AplLrCYs130_provenance.
• NP111766.RA5Rwaut2L5zLt5jzfJTSi22wvqggEkIx3vpFsmtB-YuU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111766.RA5Rwaut2L5zLt5jzfJTSi22wvqggEkIx3vpFsmtB-YuU130_provenance.
• NP111906.RAFwPrAl6qGn7D9TsQhj5XGMLyWCoVVAcYhItPT6N-vVU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111906.RAFwPrAl6qGn7D9TsQhj5XGMLyWCoVVAcYhItPT6N-vVU130_provenance.
• NP112197.RAOrl6buBtkpCtbMcPEn1MprCQtkvHn3bATy2PF4RIlPI130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112197.RAOrl6buBtkpCtbMcPEn1MprCQtkvHn3bATy2PF4RIlPI130_provenance.
• NP112200.RAIwh31qlAq-lTvjlYopJUPtFKlB_eyU3kJ_kr1Q464VU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112200.RAIwh31qlAq-lTvjlYopJUPtFKlB_eyU3kJ_kr1Q464VU130_provenance.
• NP123436.RAMpo-5IaSrKUGYyPCFF8qGsDxmQT2c1px-2ENAS5eHfM130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123436.RAMpo-5IaSrKUGYyPCFF8qGsDxmQT2c1px-2ENAS5eHfM130_provenance.
• NP123442.RAIaQEFIumFO4za_SYUw55-iPC4Z05KMJdbjHeBRbZHfw130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123442.RAIaQEFIumFO4za_SYUw55-iPC4Z05KMJdbjHeBRbZHfw130_provenance.
• NP123446.RAK6Q3V1KpuUzlZDci6pNbbFqtC6YB6vujJ2GzWgs-pqc130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123446.RAK6Q3V1KpuUzlZDci6pNbbFqtC6YB6vujJ2GzWgs-pqc130_provenance.
• NP123433.RA_o1zN6sopf3jHDGBUuLp7FS-XWnja0W2_3LaYktRDuo130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123433.RA_o1zN6sopf3jHDGBUuLp7FS-XWnja0W2_3LaYktRDuo130_provenance.
• NP123434.RA1MnQppJSs7mPsGOTqXXKIiZ7zlyF7cT9GCzjmqA42MA130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123434.RA1MnQppJSs7mPsGOTqXXKIiZ7zlyF7cT9GCzjmqA42MA130_provenance.
• NP123437.RA_wHYHEhbGy74Hs4Xgz4VoqoHdJtm6rgeyNB9ESy1JwY130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123437.RA_wHYHEhbGy74Hs4Xgz4VoqoHdJtm6rgeyNB9ESy1JwY130_provenance.
• NP123438.RA-GEg7t8-HMR8Ftrnm2ha9Gb0HxLJ_dfnHC8Yo1YdwoU130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123438.RA-GEg7t8-HMR8Ftrnm2ha9Gb0HxLJ_dfnHC8Yo1YdwoU130_provenance.
• NP123440.RA-tuNB5X8dBLJADQjKyEZkiNYTqIbyVaxBJCfw9Oades130_assertion description "[Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP123440.RA-tuNB5X8dBLJADQjKyEZkiNYTqIbyVaxBJCfw9Oades130_provenance.